stockrow
Saturday 7 November 2026
Export CLOV’s income statement to Excel — free account
Clover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
4.82
0.34
+7.59%
Follow CLOV
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 4 | 3 |
+8 more TTM periods Free account |
| 3.40% | (5.10%) | (16.86%) | (26.33%) | ||
| 1.90% | (2.84%) | (8.89%) | (15.25%) | ||
ROIC |
1.99% | (8.62%) | (26.18%) | (28.37%) | |
Return on Tangible Assets |
6.32% | (10.84%) | (48.12%) | (81.15%) | |
Average Days of Receivables |
12.67 | 10.78 | 12.13 | 17.99 | |
Free Cash Flow per Share |
0.25 | 0.14 | 0.10 | (0.13) | |
Free Cash Flow |
132.28 | 74.21 | 54.54 | (68.98) | |
Capital Expenditures |
(3.03) | (2.82) | (2.71) | (2.04) | |
| Other line items | |||||
Cash ROIC |
33.84% | 11.98% | 10.05% | (16.08%) | |
Accounts Receivable Turnover |
35.80 | 41.27 | 34.82 | 26.29 | |
Accounts Payable Turnover |
66.60 | 58.16 | 51.77 | 44.32 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
5.55 | 6.41 | 7.92 | 8.43 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 19.23% | 20.88% | 22.85% | |
Share Based Compensation of Revenue |
1.98% | 2.92% | 4.05% | 5.39% | |
Operating CF/Net income |
10.87 | (4.20) | (1.01) | 0.78 | |
Depreciation/Fixed assets |
0.04 | 0.02 | (0.02) | (0.02) | |
Capex/Depreciation |
(10.24) | (20.32) | 24.21 | 13.01 | |
Revenue per Share |
5.15 | 4.72 | 4.23 | 3.76 | |
Operating CF per Share |
0.25 | 0.15 | 0.11 | (0.13) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026